Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study

Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer

(2015) D. Pettersson et al.   BRITISH JOURNAL OF SURGERY

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

(2015) Carmen J. Allegra et al.   JNCI-Journal of the National Cancer Institute

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

(2015) Claus Rödel et al.   LANCET ONCOLOGY

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients

(2015) Maria Napolitano et al.   Oncotarget

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

(2015) Carmen J. Allegra et al.   JNCI-Journal of the National Cancer Institute

Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer

(2014) Robert J. Myerson et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study

(2013) D. Tyc-Szczepaniak et al.   ANNALS OF ONCOLOGY

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer†

(2013) T. H. van Dijk et al.   ANNALS OF ONCOLOGY

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial

(2013) Per J Nilsson et al.   BMC CANCER

Neoadjuvant treatment for unresectable rectal cancer: An interim analysis of a multicentre randomized study

(2013) Krzysztof Bujko et al.   RADIOTHERAPY AND ONCOLOGY

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

(2012) Samuel Y. Ngan et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer

(2012) Jean-Pierre Gérard et al.   JOURNAL OF CLINICAL ONCOLOGY

T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen

(2011) Ingrid S. Martijnse et al.   ANNALS OF SURGICAL ONCOLOGY

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

(2011) Carlo Aschele et al.   JOURNAL OF CLINICAL ONCOLOGY

Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases

(2011) Sang Shin et al.   Radiation Oncology

Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer

(2008) Morten Brændengen et al.   JOURNAL OF CLINICAL ONCOLOGY

Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study

(2008) Calin Radu et al.   RADIOTHERAPY AND ONCOLOGY